药物研究
XU Yan;CHEN Zhongqing;YU Ranghui;LI Guofeng;WANG Xiaoqiao
2009, 28(11): 1427-1431.
ObjectiveTo prepare sustainedrelease PLGA microspheres containing ropicavaine and dexamethasone (RopDexPLGAMS) and study drug release in vitro. MethodsRopDexPLGAMS was prepared with PLGA as carrier by a waterinoilinwater(W1/O/W2) dubleemulsion solvent evaporation method. Effects of various preparation parameters, such as polymer concentration, continuous phase/organic phase(CP/OP) ratio, volume of internal water phase and stabilizer PVA concentration on the properties of microspheres, such as particle size, morphology, drug loading, encapsulation efficiency and burst release in vitro were examined. ResultsPLGA levels was a critical factor for preparing microspheres and particle size; drug loading, encapsulation efficiency were increased significantly with increasing PLGA accompanied by a remarkably decreased burst release. The particles size, drug loading, encapsulation efficiency increased considerably, the surface of microspheres was smoother and burst release decreased as the volume ratio of CP/OP increased. Porous matrix in microspheres augmented, burst release increased and drug loading, encapsulation efficiency decreased with the higher volume of internal water phase. Particle size decreased and burst release increased as PVA concentration in the continuous phase was increased from 0.5% to 2%.By optimizing the prepare technology, RopDexPLGAMs were achieved with spherical shape, smooth surface and evenly distributed. Approximately 90% of microspheres were within the range of 20~70 μm in size. The drug loading of ropivacaine and dexamethasone were (7.48±0.33)% and (1.52±0.16)%, and encapsulation efficiencies were (70.97±2.36)% and (57.30±1.17)%, respectively. ConclusionThe duble emulsion solvent evaporation method is applicable for preparation of RopDexPLGAMs. The microspheres have a good appearance and significant in vitro sustainedrelease characteristics as a typical Sshaped and threephase.